| 1A4J | A:113-217; L:113-217 | DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR |
| 1A4K | A:113-211; L:113-212 | DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE |
| 1AD0 | A:108-213; C:108-213 | FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7 |
| 1AD9 | A:108-213; L:108-213 | IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01 |
| 1AJ7 | L:110-214 | IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY |
| 1AXS | A:108-211; L:108-211 | MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN |
| 1B2W | L:108-214 | COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY |
| 1B4J | L:108-214 | COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY |
| 1B6D | A:108-212; B:108-212 | BENCE JONES PROTEIN DEL: AN ENTIRE IMMUNOGLOBULIN KAPPA LIGHT-CHAIN DIMER |
| 1BBJ | A:110-211; L:110-211 | CRYSTAL STRUCTURE OF A CHIMERIC FAB' FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS |
| 1BEY | L:108-214 | ANTIBODY TO CAMPATH-1H HUMANIZED FAB |
| 1BJ1 | J:108-213; L:108-213 | VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY |
| 1BZ7 | A:108-206 | FAB FRAGMENT FROM MURINE ASCITES |
| 1C5B | L:108-214 | DECARBOXYLASE CATALYTIC ANTIBODY 21D8 UNLIGANDED FORM |
| 1C5C | L:108-214 | DECARBOXYLASE CATALYTIC ANTIBODY 21D8-HAPTEN COMPLEX |
| 1CE1 | L:108-211 | 1.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN |
| 1CLY | L:109-214 | IGG FAB (HUMAN IGG1, KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER |
| 1CZ8 | L:108-213; X:108-213 | VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY |
| 1D5B | A:108-211; L:108-211 | UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY |
| 1D5I | L:108-211 | UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY |
| 1D6V | L:108-211 | CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION |
| 1DEE | A:108-214; C:1108-1214; E:2108-2214 | CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY |
| 1DFB | L:107-212 | STRUCTURE OF A HUMAN MONOCLONAL ANTIBODY FAB FRAGMENT AGAINST GP41 OF HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 1DN0 | A:108-215; C:108-215 | STRUCTURE OF THE FAB FRAGMENT FROM A HUMAN IGM COLD AGGLUTININ |
| 1FL5 | A:108-212; L:108-212 | THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4. |
| 1FL6 | A:108-212; L:108-212 | THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4 |
| 1FVD | A:108-214; C:108-214 | X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING |
| 1FVE | A:108-214; C:108-214 | X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING |
| 1G9M | L:110-214 | HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B |
| 1G9N | L:110-214 | HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B |
| 1GAF | L:110-214 | 48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID |
| 1GC1 | L:110-213 | HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY |
| 1HEZ | A:108-214; C:108-214 | ANTIBODY-ANTIGEN COMPLEX |
| 1HKL | L:110-214 | FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY |
| 1HZH | L:108-214; M:108-214 | CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN |
| 1I7Z | A:108-214; C:108-214 | ANTIBODY GNC92H2 BOUND TO LIGAND |
| 1I9R | L:112-215; M:112-215; Y:112-215 | STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY |
| 1IQD | A:109-212 | HUMAN FACTOR VIII C2 DOMAIN COMPLEXED TO HUMAN MONOCLONAL BO2C11 FAB. |
| 1IT9 | L:112-214 | CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT FROM A HUMANIZED VERSION OF THE ANTI-HUMAN FAS ANTIBODY HFE7A |
| 1JPS | L:108-213 | CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44 |
| 1JPT | L:108-213 | CRYSTAL STRUCTURE OF FAB D3H44 |
| 1L7I | L:108-214 | CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4 |
| 1MHP | L:107-213 | CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY |
| 1MIM | L:106-210 | IGG FAB FRAGMENT (CD25-BINDING) |
| 1N0X | L:108-214; M:108-214 | CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE |
| 1N7M | H:108-213 | GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN |
| 1N8Z | A:108-214 | CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN HER2 COMPLEXED WITH HERCEPTIN FAB |
| 1NGW | A:108-213; L:108-213 | CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN |
| 1NGX | A:108-213; L:108-213 | CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND |
| 1NGY | A:108-213 | CHIMERIC MATURE FAB 7G12-APO |
| 1NGZ | A:108-213 | CHIMERIC GERMLINE FAB 7G12-APO |
| 1OM3 | L:108-213; M:108-213 | FAB 2G12 UNLIGANDED |
| 1OP3 | K:108-212; L:108-212 | CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN |
| 1OP5 | K:108-213; L:108-213 | CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2 |
| 1PG7 | L:108-213; M:108-213 | MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB |
| 1PKQ | A:108-213; F:108-210 | MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX |
| 1QLR | A:108-214; C:108-214 | CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ |
| 1RHH | A:107-213; C:107-213 | CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION |
| 1RZ7 | L:108-213 | CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 48D |
| 1RZ8 | A:110-212; C:110-212 | CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B |
| 1RZG | B:108-213; D:108-214 | CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D |
| 1RZI | A:108-213; C:108-213; E:108-213; G:108-213; I:108-213; K:108-213; M:108-213; O:108-213 | CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB |
| 1RZJ | L:110-212 | HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B |
| 1RZK | L:110-212 | HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B |
| 1S3K | L:113-216 | CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE |
| 1S78 | C:108-214; E:108-214 | INSIGHTS INTO ERBB SIGNALING FROM THE STRUCTURE OF THE ERBB2-PERTUZUMAB COMPLEX |
| 1T04 | A:109-214; C:109-214 | THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP |
| 1T3F | A:109-214 | THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB (HUZAF) IN P21 21 21 SPACE GROUP |
| 1TJG | L:108-214 | CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 7MER EPITOPE |
| 1TJH | L:108-214 | CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 11MER EPITOPE |
| 1TJI | L:108-214 | CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 17MER EPITOPE |
| 1TZH | A:108-211; L:108-211 | CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF |
| 1TZI | A:108-211 | CRYSTAL STRUCTURE OF THE FAB YADS2 COMPLEXED WITH H-VEGF |
| 1U8H | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWAS |
| 1U8I | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAN |
| 1U8J | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAG |
| 1U8K | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASL |
| 1U8L | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE DLDRWAS |
| 1U8M | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKYAS |
| 1U8N | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKFAS |
| 1U8O | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKHAS |
| 1U8P | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ECDKWCS |
| 1U8Q | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELEKWAS |
| 1U91 | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG ENDKW-[DAP]-S (CYCLIC) |
| 1U92 | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG E-[DAP]-DKWQS (CYCLIC) |
| 1U93 | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG EQDKW-[DAP]-S (CYCLIC) |
| 1U95 | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDHWAS |
| 1UCB | L:109-214 | STRUCTURE OF UNCOMPLEXED FAB COMPARED TO COMPLEX (1CLY, 1CLZ) |
| 1UJ3 | A:108-214 | CRYSTAL STRUCTURE OF A HUMANIZED FAB FRAGMENT OF ANTI-TISSUE-FACTOR ANTIBODY IN COMPLEX WITH TISSUE FACTOR |
| 1UM4 | L:110-217 | CATALYTIC ANTIBODY 21H3 WITH HAPTEN |
| 1UM5 | L:110-217 | CATALYTIC ANTIBODY 21H3 WITH ALCOHOL SUBSTRATE |
| 1UM6 | L:110-217 | CATALYTIC ANTIBODY 21H3 |
| 1UWE | L:108-212; U:108-212; X:108-212 | MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9 |
| 1UWG | L:108-213; X:108-213 | MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9 |
| 1VGE | L:108-214 | TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY |
| 1Y0L | A:108-212; C:108-212; E:108-212; L:108-212 | CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN |
| 1Y18 | A:108-212; C:108-212; E:108-212; L:108-212 | FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN |
| 1YYL | L:108-212; Q:1108-1212 | CRYSTAL STRUCTURE OF CD4M33, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B |
| 1YYM | L:108-212; Q:1108-1212 | CRYSTAL STRUCTURE OF F23, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B |
| 1ZA3 | A:107-213; L:107-213 | THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5 |
| 2B4C | L:108-214 | CRYSTAL STRUCTURE OF HIV-1 JR-FL GP120 CORE PROTEIN CONTAINING THE THIRD VARIABLE REGION (V3) COMPLEXED WITH CD4 AND THE X5 ANTIBODY |
| 2F5A | L:108-213 | CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 |
| 2F5B | L:108-214 | CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH ITS GP41 EPITOPE |
| 2FEC | L:107-210; O:107-210 | STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI |
| 2FED | D:107-210; F:107-210 | STRUCTURE OF THE E203Q MUTANT OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI |
| 2FEE | L:107-210; O:107-210 | STRUCTURE OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI IN NABR |
| 2FGW | L:109-214 | X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY: STRUCTURAL INDICATIONS OF THE KEY ROLE OF VH RESIDUES 59 TO 65 |
| 2FX7 | L:108-213 | CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 16-RESIDUE PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41 |
| 2FX8 | L:108-213; M:108-213; N:108-213; O:108-213 | CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41 |
| 2FX9 | L:108-213; M:108-213 | CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41 |
| 2HH0 | L:153-271 | STRUCTURE OF AN ANTI-PRP FAB, P-CLONE, IN COMPLEX WITH ITS COGNATE BOVINE PEPTIDE EPITOPE. |
| 2HWZ | L:107-213 | FAB FRAGMENT OF HUMANIZED ANTI-VIRAL ANTIBODY MEDI-493 (SYNAGIS TM) |
| 2I5Y | L:108-212; Q:108-212 | CRYSTAL STRUCTURE OF CD4M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B |
| 2I60 | L:108-212; Q:108-212 | CRYSTAL STRUCTURE OF [PHE23]M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B |
| 2NXY | C:2112-2214 | HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B |
| 2NXZ | C:2112-2214 | HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T257S, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B |
| 2NY0 | C:2112-2214 | HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, T257S, V275C, S334A, S375W, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B |
| 2NY1 | C:2112-2214 | HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C, T257S, S334A, S375W, Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B |
| 2NY2 | C:2112-2214 | HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T123C, T257S, S334A, S375W, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B |
| 2NY3 | C:2112-2214 | HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E267C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B |
| 2NY4 | C:2112-2214 | HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C, T257S, E268C, S334A, S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B |
| 2NY5 | L:2112-2214 | HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B |
| 2NY6 | C:2112-2214 | HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B |
| 2NY7 | L:108-214 | HIV-1 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH THE BROADLY NEUTRALIZING CD4-BINDING-SITE ANTIBODY B12 |
| 2NZ9 | C:115-215; E:115-215 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2 |
| 2PR4 | L:108-213 | CRYSTAL STRUCTURE OF FAB' FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 |
| 2QR0 | A:108-211; E:108-211; G:108-211; K:108-211; M:108-211; Q:108-211; S:108-211; W:108-211 | STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS |
| 2QSC | L:108-214 | CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3-FAB F425-B4E8 IN COMPLEX WITH A V3-PEPTIDE |
| 2RCS | L:110-214 | IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY |
| 2ZKH | L:108-210 | HUMAN THROMBOPOIETIN NEUTRALIZING ANTIBODY TN1 FAB |
| 3CFJ | A:107-213; C:107-213; E:107-213; L:107-213 | CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM |
| 3CFK | A:108-212; C:108-212; E:108-212; G:108-212; J:108-212; L:108-212; M:108-212; O:108-212 | CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, TRICLINIC CRYSTAL FORM |
| 3DVG | A:110-214 | CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU.3A8 BOUND TO K63-LINKED DI-UBIQUITIN |
| 3DVN | A:110-214; L:110-214 | CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU2.16 BOUND TO K63-LINKED DI-UBIQUITIN |
| 3EYV | A:113-219; L:113-216 | ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS |
| 3FCT | A:108-213; C:108-213 | MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN |
| 3IDG | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWD |
| 3IDI | A:108-213 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ALDKWNQ |
| 3IDJ | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(ORN)WAS |
| 3IDM | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(NRG)WAS |
| 3IDN | A:108-214 | CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(PAF)WAS |
| 3LEV | L:108-214 | HIV-1 ANTIBODY 2F5 IN COMPLEX WITH EPITOPE SCAFFOLD ES2 |
| 3OAU | L:108-213 | ANTIBODY 2G12 RECOGNIZES DI-MANNOSE EQUIVALENTLY IN DOMAIN- AND NON-DOMAIN-EXCHANGED FORMS, BUT ONLY BINDS THE HIV-1 GLYCAN SHIELD IF DOMAIN-EXCHANGED |
| 4DVR | L:107-212 | CRYSTAL STRUCTURE OF YU2 GP120 CORE IN COMPLEX WITH FAB 48D AND NBD-557 |
)
)